Transforming Oncology Through

Science and AI Technology

About Onco-Innovations

About Onco-Innovations

Onco-Innovations pioneers cancer research, developing cutting-edge therapies to prevent and treat cancer. With exclusive global rights to groundbreaking technology targeting solid tumors, our aim is to set new targets in oncology, improving patient outcomes and offering hope.

Through the acquisition of Inka Health and its SynoGraph™ AI platform, we are enhancing precision oncology by accelerating patient identification, optimizing treatment planning, and streamlining drug development across our pipeline

ONC010ᵀᴹ

The Next-Generation Drug Formulation

Our Proprietary Lead Drug Candidate ONC010 Utilizes 100% Licensed PNKP Inhibitor Technology

Our Proprietary Lead Drug Candidate ONC010 Utilizes 100% Licensed PNKP Inhibitor Technology

Proprietary Formula

Aims to prevent DNA repair to eliminate cancer cells

Enhanced Delivery

Nanoparticles ensure precision targeting

Optimized Results

Designed to work with chemo/radiation/surgery to potentially improve outcomes and reduce side effects

Global Cancer Market Size

Global Cancer Market Size

An Immense Investment Opportunity in Oncology¹

Onco-Innovations pioneers cancer research, developing cutting-edge therapies to prevent and treat cancer. With exclusive global rights to groundbreaking technology targeting solid tumors, we set new benchmarks in oncology, improving patient outcomes and offering hope.

10 Year Growth Projection

Market Value in Billions $(USD)

131%

131%

Aggregate Growth Expected by 2032 to $497B¹ ³

Aggregate Growth Expected by 2032 to $497B¹ ³

Global cancer cases are projected to rise by 47% by 2040²

CAGR of 8.9%³

Existing treatment gaps in precision medicine and early diagnostics

Addressable market: Colorectal cancer alone represents a $18 billion market

Unmet needs include faster diagnostics and cost-effective therapies

Get in Touch with Us

Onco-Innovations Limited

Tel: 1 (888) 261 – 8055

investors@oncoinnovations.com

1309 – 7th Street SW
Calgary, Alberta, Canada
T2R 1A5

Tel: 1 (888) 261 – 8055

investors@oncoinnovations.com

1309 – 7th Street SW
Calgary, Alberta, Canada
T2R 1A5

Onco-Innovations pioneers cancer research, developing

cutting-edge therapies to treat cancer.

Reach Us

1309 – 7th Street SW
Calgary, Alberta, Canada
T2R 1A5

investors@oncoinnovations.com

+1 (888) 261–8055

© 2025 Onco-Innovations Limited | All Rights Reserved

Onco-Innovations pioneers cancer research, developing

cutting-edge therapies to treat cancer.

Reach Us

1309 – 7th Street SW
Calgary, Alberta, Canada
T2R 1A5

investors@oncoinnovations.com

+1 (888) 261–8055

© 2025 Onco-Innovations Limited | All Rights Reserved

Onco-Innovations pioneers cancer research, developing

cutting-edge therapies to treat cancer.

Reach Us

1309 – 7th Street SW
Calgary, Alberta, Canada
T2R 1A5

investors@oncoinnovations.com

+1 (888) 261–8055

© 2025 Onco-Innovations Limited | All Rights Reserved

Onco-Innovations pioneers cancer research, developing

cutting-edge therapies to treat cancer.

Reach Us

1309 – 7th Street SW
Calgary, Alberta, Canada
T2R 1A5

investors@oncoinnovations.com

+1 (888) 261–8055

© 2025 Onco-Innovations Limited | All Rights Reserved